![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Boceprevir Plus Peginterferon/Ribavirin for the Treatment of HCV/HIV Co-Infected Patients
|
|
|
Reported by Jules Levin
19th Conference on Retroviruses and Opportunistic Infections (CROI)
Seattle, WA
March 6, 2012
M Sulkowski1, S Pol2, C Cooper3, H Fainboim4, J Slim5, A Rivero6, M Laguno7, S Thompson8, J Wahl8, W Greaves8
1John Hopkins University School of Medicine, Baltimore, MD; 2Hopital Cochin, Paris, France; 3The Ottawa Hospital, Ottawa, ON, Canada; 4F. J. Muniz Hospital De Infecciosas, Buenos Aires, Argentina; 5Saint Michael's Medical Center, Newark, NJ; 6Hospital Universitario Reina Sofia, Cordoba, Spain, 7Hospital Clinic i Provincial Barcelona, Spain; 8Merck Sharp & Dohme, Whitehouse Station, NJ.
![CROI1.gif](../images/030712/030712-10/CROI1.gif)
![CROI2.gif](../images/030712/030712-10/CROI2.gif)
![CROI3.gif](../images/030712/030712-10/CROI3.gif)
![CROI4.gif](../images/030712/030712-10/CROI4.gif)
![CROI5.gif](../images/030712/030712-10/CROI5.gif)
![CROI6.gif](../images/030712/030712-10/CROI6.gif)
![CROI7.gif](../images/030712/030712-10/CROI7.gif)
![CROI8.gif](../images/030712/030712-10/CROI8.gif)
![CROI9.gif](../images/030712/030712-10/CROI9.gif)
![CROI10.gif](../images/030712/030712-10/CROI10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|